17835, Laurelton, Pennsylvania Prostate Cancer Score Provider Score

The Provider Score for the Prostate Cancer Score in 17835, Laurelton, Pennsylvania is 42 when comparing 34,000 ZIP Codes in the United States.

An estimate of 100.00 percent of the residents in 17835 has some form of health insurance. 56.60 percent of the residents have some type of public health insurance like Medicare, Medicaid, Veterans Affairs (VA), or TRICARE. About 89.62 percent of the residents have private health insurance, either through their employer or direct purchase. Military veterans should know that percent of the residents in the ZIP Code of 17835 have VA health insurance. Also, percent of the residents receive TRICARE.

For the 55 residents under the age of 18, there is an estimate of 1 pediatricians in a 20-mile radius of 17835. An estimate of 0 geriatricians or physicians who focus on the elderly who can serve the 1 residents over the age of 65 years.

In a 20-mile radius, there are 2,433 health care providers accessible to residents in 17835, Laurelton, Pennsylvania.

## Prostate Cancer Score: Laurelton, PA (ZIP Code 17835) – An Analysis

The health landscape of Laurelton, Pennsylvania (ZIP Code 17835) presents a complex picture when assessing its readiness to address prostate cancer detection and care. This analysis evaluates the available resources, focusing on primary care accessibility, physician-to-patient ratios, the presence of specialized practices, and the adoption of modern technologies like telemedicine, along with the crucial integration of mental health support. The goal is to provide a comprehensive 'Prostate Cancer Score' analysis, offering insights for residents seeking proactive healthcare.

Primary care is the cornerstone of early prostate cancer detection. Regular check-ups, including prostate-specific antigen (PSA) tests and digital rectal exams (DREs), are vital for identifying potential issues early. The availability of primary care physicians (PCPs) within Laurelton and its surrounding areas is therefore a critical factor. Analyzing the physician-to-patient ratio provides a glimpse into access. A higher ratio, meaning fewer doctors for a larger population, can lead to longer wait times for appointments and potentially delayed diagnoses. Publicly available data from sources like the Pennsylvania Department of Health and the US Census Bureau can be used to estimate these ratios, providing a baseline for understanding access limitations.

Specialized practices, particularly urology clinics, are essential for advanced diagnosis and treatment. The presence of board-certified urologists in or near Laurelton significantly impacts the 'Prostate Cancer Score'. Proximity to these specialists facilitates timely consultations, biopsies, and treatment planning. The availability of advanced diagnostic tools, such as MRI and ultrasound, within these practices further enhances the score. These tools are instrumental in accurately staging the cancer and tailoring treatment plans. The location of these specialists and the ease of referral from primary care providers are critical considerations.

Telemedicine offers a significant advantage in rural areas like Laurelton. It allows patients to consult with specialists remotely, reducing the need for travel and potentially improving access to care, particularly for follow-up appointments and consultations. The adoption rate of telemedicine by primary care physicians and urologists in the region is a key indicator of the score. Practices that embrace telemedicine demonstrate a commitment to patient convenience and access, especially for those facing mobility challenges or geographical barriers.

Mental health resources are often overlooked but play a crucial role in cancer care. A prostate cancer diagnosis can be emotionally taxing, leading to anxiety, depression, and other mental health challenges. The availability of mental health professionals, such as therapists and counselors, within the Laurelton community is an important element of the score. Integration of mental health services into primary care or urology practices, or clear referral pathways to mental health providers, significantly enhances the overall quality of care. This holistic approach ensures that patients receive comprehensive support throughout their journey.

The 'Prostate Cancer Score' is also influenced by the presence of standout practices. These are healthcare providers who demonstrate excellence in prostate cancer care. Factors that contribute to this include a commitment to early detection through regular screening, the use of evidence-based treatment protocols, participation in clinical trials, and a patient-centered approach. Identifying these practices and highlighting their best practices is crucial for residents seeking the best possible care. Reviews from patients and data from reputable sources can help identify these high-performing providers.

Assessing the 'Prostate Cancer Score' also necessitates an understanding of the local healthcare infrastructure. This includes the presence of hospitals and cancer centers in the vicinity, the availability of radiation therapy and chemotherapy services, and the overall coordination of care. The ability of healthcare providers to collaborate effectively, sharing patient information and coordinating treatment plans, is a critical factor. The establishment of multidisciplinary teams, involving urologists, oncologists, radiation therapists, and other specialists, further enhances the score.

In Laurelton, the score is influenced by the demographic makeup of the population. The prevalence of prostate cancer increases with age, and the racial and ethnic composition of the community can also play a role. Understanding the specific needs of the local population is crucial for tailoring healthcare services and ensuring equitable access to care. Public health initiatives aimed at raising awareness about prostate cancer and promoting early detection are also important factors.

The 'Prostate Cancer Score' is not static; it evolves with the changing healthcare landscape. The adoption of new technologies, the development of innovative treatments, and the changing needs of the population all influence the score. Continuous monitoring and evaluation of the local healthcare resources are essential for ensuring that residents have access to the best possible care. This requires ongoing collaboration between healthcare providers, public health officials, and community organizations.

Overall, the 'Prostate Cancer Score' for Laurelton, PA (ZIP Code 17835) is a multifaceted assessment. It reflects the availability of primary care, the presence of specialized practices, the adoption of telemedicine, the integration of mental health resources, and the overall quality of the local healthcare infrastructure. While a detailed numerical score requires specific data analysis, this overview provides a framework for understanding the key factors that contribute to prostate cancer care in the region. Residents can use this information to make informed decisions about their healthcare and advocate for improvements in the local healthcare system.

For a more visual and geographically informed understanding of the healthcare landscape in Laurelton, PA, and to identify the location of primary care physicians, urologists, and other relevant healthcare resources, we encourage you to explore the interactive maps available through CartoChrome.